Skip to main content
OpenTrials

Clinical trial condition

Relapsing Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

83 public trials 5 recruiting studies

Relapsing Remitting Multiple Sclerosis trial results

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Teva Investigational Site 1332 Birmingham, Alabama, United States
  • Teva Investigational Site 1327 Gilbert, Arizona, United States
  • Teva Investigational Site 1311 Phoenix, Arizona, United States
  • Teva Investigational Site 1326 Fullerton, California, United States
View all 176 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Sun City, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 123 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Hospital Fernando Fonseca Amadora, Portugal
  • Hospital de Braga Braga, Portugal
  • Centro Hospitalar Cova da Beira Covilha, Portugal
  • Hospital Evora Evora, Portugal
View all 15 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Centre d'investigation Clinique - Pitié salpêtrière Paris, France
  • Centre d'investigation clinique Biothérapie Immunologie (CIC-BTi) - Groupe Hospitalier Pitié-Salpêtrière - AP-HP Paris, France
  • Département des maladies du système nerveux et Centre d'investigation clinique - Groupe Hospitalier Pitié-Salpêtrière - AP-HP Paris, France
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Tucson, Arizona, United States
  • Alkermes Investigational Site Long Beach, California, United States
View all 67 locations